Lawrence F. Eichenfield, MD, Lisa Beck, MD

Slides:

Advertisements

Similar presentations

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

Advertisements

Wet Wrap Therapy in Children with Moderate to Severe Atopic Dermatitis in a Multidisciplinary Treatment Program Noreen Heer Nicol, PhD, RN, FNP, Mark.

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Evaluation and treatment of allergic fungal sinusitis. II

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children Mark Boguniewicz, MDa, Virginia C. Fiedler,

Predominance of type 2 cytokine–producing CD4+ and CD8+ cells in patients with atopic dermatitis Masatoshi Nakazawa, DVMa, Nakako Sugi, MDb, Hiroshi.

Evaluation and treatment of allergic fungal sinusitis. II

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild.

Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.

Overcoming barriers to nonadherence in asthma treatment

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies Mark.

Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: An open-label pilot.

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Badrul A. Chowdhury, MD, PhD

An Infant with Atopic Dermatitis and Itching After Ingestion of Milk

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

Predictors of positive food challenge outcome in non–IgE-mediated reactions to food in children with atopic dermatitis Bodo Niggemann, MD, Susanne Reibel,

Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity Csaba Szalai, PhD, Gergely T. Kozma, BSc, Adrienne.

The impact of allergic rhinitis on bronchial asthma

Conjunctivitis medicamentosa

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis.

Inhaled corticosteroids: Impact on asthma morbidity and mortality

Michael Mellon, MD Journal of Allergy and Clinical Immunology

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

News & Notes Journal of Allergy and Clinical Immunology

Effect of probiotic Lactobacillus strains in children with atopic dermatitis Vibeke Rosenfeldt, MD, PhDa,b, Eva Benfeldt, MD, PhDc, Susanne Dam Nielsen,

The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells Juha Punnonen, MD, PhD, Hans Yssel, PhD,

Circadian variation of sputum inflammatory cells in mild asthma

Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Recruitment of T cells to the lung in response to antigen challenge

6. Asthma Journal of Allergy and Clinical Immunology

Effect of ozone and nitrogen dioxide on the release of proinflammatory mediators from bronchial epithelial cells of nonatopic nonasthmatic subjects and.

Natural history of Hymenoptera venom sensitivity in adults

Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants Roland Kaufmann, MD, Regina Fölster-Holst, MD, Peter Höger, MD,

Exercise-induced bronchoconstriction in children: Montelukast attenuates the immediate-phase and late-phase responses Raul E. Melo, MD, Dirceu Solé,

Clinical need for a nebulized corticosteroid

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

News & Notes Journal of Allergy and Clinical Immunology

Aaron M. Drucker, MD, Paula J. Harvey, PhD

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand’s disease in a family cluster Pramod S. Kelkar, MD, Rosa M. Ten,

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease.

Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study Giovanni B. Pajno,

Clinical effects of nedocromil sodium on challenges invoking neuronal mechanisms and on virally induced symptoms Peter König, MD, PhD Journal of Allergy.

Harald Renz, MD, Chaya Brodie, PhD, Katherine Bradley, BS, Donald Y. M

Therapeutic strategies to reduce asthma exacerbations

The role and remediation of animal allergens in allergic diseases

Corticosteroids in the treatment of pediatric allergic rhinitis

Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen Catherine.

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma James P.

Determinants of systemic manifestations of food allergy

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a.

Robert P. Schleimer, PhD Journal of Allergy and Clinical Immunology

Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma Sally E. Wenzel, MD Journal of Allergy and Clinical.

Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle.

Larry C. Borish, MDa, Harold S

Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.

The environmental predictors of allergic disease

Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection Alexander A. Navarini, MD, PhD, Lars E.

News & Notes Journal of Allergy and Clinical Immunology

Lisa A. Beck, MD, Sarbjit Saini, MD

Desloratadine: A new, nonsedating, oral antihistamine

Presentation transcript:

Elidel (pimecrolimus) cream 1%: A nonsteroidal topical agent for the treatment of atopic dermatitis Lawrence F. Eichenfield, MD, Lisa Beck, MD Journal of Allergy and Clinical Immunology Volume 111, Issue 5, Pages 1153-1168 (May 2003) DOI: 10.1067/mai.2003.1492 Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 1 Macrolactams block inflammatory cytokine transcription in activated T cells. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 2 Pimecrolimus is different from tacrolimus: lipophilicity distribution. Blue indicates hydrophilic regions; brown indicates lipophilic regions. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 3 Elidel pediatric study: percentage of subjects with mild or no pruritus. DB, Double-blind; OL, open label. *P < .001. Reproduced with permission from Eichenfield et al. J Am Acad Dermatol, Vol. 46, Page 500, Figure 4, copyright 2002. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 4 Elidel pediatric study: percentage of subjects “clear” or “almost clear” of AD (IGA score 0 or 1). Reproduced with permission from Eichenfield et al. J Am Acad Dermatol, Vol. 46, Page 498, Figure 1, copyright 2002. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 5 Elidel pediatric study: EASI mean percentage change from baseline (overall, head, and neck). Reproduced with permission from Eichenfield et al. J Am Acad Dermatol, Vol. 46, Page 500, Figure 3, copyright 2002. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 6 Elidel infant study: patients “clear” or “almost clear” (IGA score of 0 or 1) during double-blind (A) and open-label (B) phases. Note: After completion of the double-blind phase (day 43), patients in the vehicle-treated group were switched to pimecrolimus treatment in the open-label phase. Reproduced with permission from Ho et al. J Pediatr, Vol. 142, Page 158, Figure 4, copyright 2003. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 7 Elidel infant study: shift in IGA score status from baseline to end point (43 days; double-blind phase). Reproduced with permission from Ho et al. J Pediatr, Vol. 142, Page 158, copyright 2003. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 8 Elidel infant study: an example of an Elidel treatment success. Photos were taken at baseline (A) and day 43 (B) . Reproduced with permission from Ho et al. J Pediatr, Vol. 142, Page 157, Figure 3, copyright 2003. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 9 Design of long-term study comparing early intervention with Elidel with a conventional AD treatment strategy. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 10 Long-term management of pediatric AD with Elidel: patients with 0 flares at 6 and 12 months. Reproduced with permission from Wahn et al. Pediatrics, Vol. 110, Page e29, copyright 2002. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 11 Long-term management of pediatric AD: proportion of patients with 0 flares after 6 months by disease severity at baseline. Reproduced with permission from Wahn et al. Pediatrics, Vol. 110, Page e29, Figure 2B, copyright 2002. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 12 Long-term management of pediatric AD: Kaplan-Meier estimate of time to first flare. Reproduced with permission from Wahn et al. Pediatrics, Vol. 110, Page e29, Figure 2A, copyright 2002. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 13 Long-term management of pediatric AD: median percentage reduction in EASI score over 12 months (Elidel vs conventional therapy). CS, Moderately potent corticosteroid. Reproduced with permission from Wahn et al. Pediatrics, Vol. 110, Page e29, Figure 2B, copyright 2002. Journal of Allergy and Clinical Immunology 2003 111, 1153-1168DOI: (10.1067/mai.2003.1492) Copyright © 2003 Mosby, Inc. Terms and Conditions